Skip to content

Perioperative Parameter and Treatment Outcomes of Surgical Treatment for Benign Prostate Hyperplasia in Hong Kong

A Prospective Assessment of the Perioperative Parameter and Treatment Outcomes of Surgical Treatment for Benign Prostate Hyperplasia in Hong Kong

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05292235
Enrollment
2000
Registered
2022-03-23
Start date
2022-04-01
Completion date
2032-07-31
Last updated
2025-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia

Brief summary

This is a prospective data registry to assess the treatment outcomes and complications of different treatment approaches in our hospital clusters.

Detailed description

Benign prostatic hyperplasia (BPH) is a very common disease affecting men. Patients with BPH may present with voiding symptoms including hesitancy, intermittence, slow stream and sensation of incomplete emptying, and storage symptoms including urinary frequency, urgency and nocturia. Patients may also suffer from complications including urinary retention, recurrent urinary tract infection, bladder stone formation and obstructive uropathy. For patients who have lower urinary tract symptoms refractory to medications, or those who suffer from complications of BPH, transurethral prostatectomy should be considered. Surgical intervention options have evolved from electrosurgical resection to the use of lasers for enucleation and ablation \[1\]. Aquablation and Rezum system are new minimally invasive surgical technology for BPH management. \[2,3,4\]. Different treatment approaches will result in different treatment successful rate and also potential adverse effects to patients. However, large-scale studies investigating the different modalities of surgical treatment of BPH are lacking. Therefore, a prospective data registry is created to assess the perioperative surgical outcomes for different surgical treatment of BPH.

Interventions

None listed

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient at the age of 18 or above

Exclusion criteria

* Patient is unable to give consent

Design outcomes

Primary

MeasureTime frameDescription
International Prostate Symptom Score (IPSS) questionnaire total ScoreBaseline, 3 months after surgical treatment for BPHChange in total scores in International Prostate Symptom Score (ranges from 0 to 35) questionnaires
Voiding function in uroflowmetryBaseline, 3 months after after surgical treatment for BPHChange in urodynamic function assessed by Uroflowmetry

Secondary

MeasureTime frameDescription
Complication after surgical treatmentPost operation 30 days after surgical treatment for BPHThe 30-day complications will be graded according to the Clavien-Dindo classification

Countries

Hong Kong

Contacts

Primary ContactChi Fai NG, MD
ngcf@surgeryh.cuhk.edu.hk35052625

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026